Skip to main content
JAMA Network logoLink to JAMA Network
. 2026 Apr 2;12(5):532. doi: 10.1001/jamaoncol.2026.0651

Error in Tables 2 and 3

PMCID: PMC13047488  PMID: 41926092

In the Original Investigation titled “Artificial Intelligence–Detected Tumor-Infiltrating Lymphocytes and Outcomes in Anti–PD-1–Based Treated Melanoma,”1 published online October 16, 2025, and in the December 2025 issue, there were errors in Tables 2 and 3. In Table 2, in the univariable column, the measures for progression-free survival and overall survival were corrected to hazard ratios; in the multivariable column, the measures for overall response rate were corrected to odds ratios. In Table 3, the measures for progression-free survival were corrected to hazard ratios. This article was corrected online.

Reference

  • 1.Schuiveling M, van Duin IAJ, ter Maat LS, et al. Artificial intelligence–detected tumor-infiltrating lymphocytes and outcomes in anti–PD-1–based treated melanoma. JAMA Oncol. 2025;11(12):1470-1478. doi: 10.1001/jamaoncol.2025.4072 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from JAMA Oncology are provided here courtesy of American Medical Association

RESOURCES